Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis Therapeutics market report explains the definition, types, applications, major countries, and major players of the Psoriasis Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Astellas Pharma Inc
Eli Lilly and Company
F Hofffmann-La Roche
G & W Laboratories Inc
Valeant Pharmaceuticals International, Inc
Merck & Co, Inc
AstraZeneca plc
GlaxoSmithKline plc
Biocon Limited
Boehringer Ingelheim GmbH
By Type:
Oral
Parenteral
Topical
By End-User:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Psoriasis Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Psoriasis Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Psoriasis Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Psoriasis Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Psoriasis Therapeutics Market- Recent Developments
-
6.1 Psoriasis Therapeutics Market News and Developments
-
6.2 Psoriasis Therapeutics Market Deals Landscape
7 Psoriasis Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Psoriasis Therapeutics Key Raw Materials
-
7.2 Psoriasis Therapeutics Price Trend of Key Raw Materials
-
7.3 Psoriasis Therapeutics Key Suppliers of Raw Materials
-
7.4 Psoriasis Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Psoriasis Therapeutics Cost Structure Analysis
-
7.5.1 Psoriasis Therapeutics Raw Materials Analysis
-
7.5.2 Psoriasis Therapeutics Labor Cost Analysis
-
7.5.3 Psoriasis Therapeutics Manufacturing Expenses Analysis
8 Global Psoriasis Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Psoriasis Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Psoriasis Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Psoriasis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Parenteral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Psoriasis Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Psoriasis Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Psoriasis Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Psoriasis Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Psoriasis Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.2 UK Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.5 France Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Psoriasis Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Psoriasis Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.3 India Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Psoriasis Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Psoriasis Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Psoriasis Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Psoriasis Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Psoriasis Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Psoriasis Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Psoriasis Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Psoriasis Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Psoriasis Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Psoriasis Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Psoriasis Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Psoriasis Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Psoriasis Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Psoriasis Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Psoriasis Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Psoriasis Therapeutics Consumption (2017-2022)
11 Global Psoriasis Therapeutics Competitive Analysis
-
11.1 Astellas Pharma Inc
-
11.1.1 Astellas Pharma Inc Company Details
-
11.1.2 Astellas Pharma Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Astellas Pharma Inc Psoriasis Therapeutics Main Business and Markets Served
-
11.1.4 Astellas Pharma Inc Psoriasis Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eli Lilly and Company
-
11.2.1 Eli Lilly and Company Company Details
-
11.2.2 Eli Lilly and Company Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eli Lilly and Company Psoriasis Therapeutics Main Business and Markets Served
-
11.2.4 Eli Lilly and Company Psoriasis Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 F Hofffmann-La Roche
-
11.3.1 F Hofffmann-La Roche Company Details
-
11.3.2 F Hofffmann-La Roche Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 F Hofffmann-La Roche Psoriasis Therapeutics Main Business and Markets Served
-
11.3.4 F Hofffmann-La Roche Psoriasis Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 G & W Laboratories Inc
-
11.4.1 G & W Laboratories Inc Company Details
-
11.4.2 G & W Laboratories Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 G & W Laboratories Inc Psoriasis Therapeutics Main Business and Markets Served
-
11.4.4 G & W Laboratories Inc Psoriasis Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Valeant Pharmaceuticals International, Inc
-
11.5.1 Valeant Pharmaceuticals International, Inc Company Details
-
11.5.2 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Main Business and Markets Served
-
11.5.4 Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Merck & Co, Inc
-
11.6.1 Merck & Co, Inc Company Details
-
11.6.2 Merck & Co, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Merck & Co, Inc Psoriasis Therapeutics Main Business and Markets Served
-
11.6.4 Merck & Co, Inc Psoriasis Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca plc
-
11.7.1 AstraZeneca plc Company Details
-
11.7.2 AstraZeneca plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca plc Psoriasis Therapeutics Main Business and Markets Served
-
11.7.4 AstraZeneca plc Psoriasis Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GlaxoSmithKline plc
-
11.8.1 GlaxoSmithKline plc Company Details
-
11.8.2 GlaxoSmithKline plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GlaxoSmithKline plc Psoriasis Therapeutics Main Business and Markets Served
-
11.8.4 GlaxoSmithKline plc Psoriasis Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Biocon Limited
-
11.9.1 Biocon Limited Company Details
-
11.9.2 Biocon Limited Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Biocon Limited Psoriasis Therapeutics Main Business and Markets Served
-
11.9.4 Biocon Limited Psoriasis Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Boehringer Ingelheim GmbH
-
11.10.1 Boehringer Ingelheim GmbH Company Details
-
11.10.2 Boehringer Ingelheim GmbH Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Main Business and Markets Served
-
11.10.4 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Psoriasis Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Psoriasis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Psoriasis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Psoriasis Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Psoriasis Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Psoriasis Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Psoriasis Therapeutics
-
Figure of Psoriasis Therapeutics Picture
-
Table Global Psoriasis Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Psoriasis Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global TNF Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Table North America Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure China Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Psoriasis Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Psoriasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Astellas Pharma Inc Company Details
-
Table Astellas Pharma Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Psoriasis Therapeutics Main Business and Markets Served
-
Table Astellas Pharma Inc Psoriasis Therapeutics Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Psoriasis Therapeutics Main Business and Markets Served
-
Table Eli Lilly and Company Psoriasis Therapeutics Product Portfolio
-
Table F Hofffmann-La Roche Company Details
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Main Business and Markets Served
-
Table F Hofffmann-La Roche Psoriasis Therapeutics Product Portfolio
-
Table G & W Laboratories Inc Company Details
-
Table G & W Laboratories Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table G & W Laboratories Inc Psoriasis Therapeutics Main Business and Markets Served
-
Table G & W Laboratories Inc Psoriasis Therapeutics Product Portfolio
-
Table Valeant Pharmaceuticals International, Inc Company Details
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Main Business and Markets Served
-
Table Valeant Pharmaceuticals International, Inc Psoriasis Therapeutics Product Portfolio
-
Table Merck & Co, Inc Company Details
-
Table Merck & Co, Inc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Psoriasis Therapeutics Main Business and Markets Served
-
Table Merck & Co, Inc Psoriasis Therapeutics Product Portfolio
-
Table AstraZeneca plc Company Details
-
Table AstraZeneca plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Psoriasis Therapeutics Main Business and Markets Served
-
Table AstraZeneca plc Psoriasis Therapeutics Product Portfolio
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Main Business and Markets Served
-
Table GlaxoSmithKline plc Psoriasis Therapeutics Product Portfolio
-
Table Biocon Limited Company Details
-
Table Biocon Limited Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited Psoriasis Therapeutics Main Business and Markets Served
-
Table Biocon Limited Psoriasis Therapeutics Product Portfolio
-
Table Boehringer Ingelheim GmbH Company Details
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Main Business and Markets Served
-
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Psoriasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Psoriasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
